National Institutes of Health· États-Unis · 13 j
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
Des conditions s'appliquent. Lisez la section sur l'éligibilité ci-dessous avant de commencer.
En bref
- Clôture le
- Publié le
- Comment candidater
- Sur leur site
S'ouvre sur leur site web. Nous n'intervenons pas dans la candidature.
À propos de cette opportunité
<p>This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials. </p><p>This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO (<a href="https://www.grants.gov/search-results-detail/360623">RFA-DK-28-214)</a>. </p>
Qui peut candidater
- Aucune restriction de pays indiquée
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Vous connaissez quelqu'un que cela intéresserait ?
Le partage reste la façon dont la plupart des gens ici apprennent une opportunité à temps.